Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.CSCI
Alternate Symbol(s):
CSCI
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CSCI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(150)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Comment by
Hopeforthebest
on Aug 31, 2024 10:59am
RE:RE:Market Cap
proph said - "We don't know exactly what the company has but the company has attracted Ronnie Miller " Was that the same NoShowRonnie who was quietly forced out under the guise of early
...more
(104)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Aug 31, 2024 10:41am
RE:Market Cap
BoazKhorn, "If this entire tird sandwich is worth 20MM then the poor Ceapro suckers who still own shares have been reduced to about 10MM in value between them." Still amazing to see
...more
Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents
posted Dec 03, 2024 9:00am by
Revive Therapeutics Ltd
-
|
Evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. ...read more
(6)
•••
BoazKhorn
X
View Profile
View Bullboard History
Post by
BoazKhorn
on Aug 31, 2024 9:06am
Market Cap
If this entire tird sandwich is worth 20MM then the poor Ceapro suckers who still own shares have been reduced to about 10MM in value between them. Or another way ,CZO had 77MM shares
...more
(104)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 31, 2024 12:06am
Dr. Li's YouTube Channel
The YouTube video in which Dr. Li described the avenanthramide and oat beta glucan wound healing research as a eureka moment cutting the time of healing in half and creating scarless wounds in one
...more
(104)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Aug 30, 2024 11:18pm
RE:New name, new listing, same old Gilles
"They have 3 or four quarters of runway and for a CEO that hasnt delivered on single thing, not one thing in 15 years..." You haven't even seen the plan. This company is asset
...more
(6)
•••
BoazKhorn
X
View Profile
View Bullboard History
Post by
BoazKhorn
on Aug 30, 2024 6:10pm
New name, new listing, same old Gilles
Hey Boys. Been gone a while sailing solo around the world. Just stopped by to see how Ceapro was doing. Glad to see Gilles is still effing up in reverse as always. The kiddy growth hormone was
...more
(104)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 30, 2024 4:15pm
Perplexity Ai on the Avenanthramide Pill:
Ceapro's pharma-grade avenanthramide pill presents a potentially compelling entry into the non-steroidal anti-inflammatory (NSAID) market, particularly when combined with yeast beta-glucan
...more
(104)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 30, 2024 2:57pm
The launch of a new company
With the merger complete and the integration plans and forward plans and priorities for the new company finalized it's time to launch the new company. The summer holidays are over and it's
...more
(104)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Aug 30, 2024 9:00am
RE:PGX-Whey
PGX Technology applied to whey has several commercial applications, primarily in the food, nutraceutical, and pharmaceutical industries. The key applications include: Whey Protein Concentrates
...more
(104)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 30, 2024 8:48am
PGX-Whey
Perplexity Ai's take: Ceapro's PGX technology applied to whey proteins offers a compelling solution for the efficient processing of these proteins, which are traditionally
...more
(104)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 30, 2024 5:59am
Macimorelin and PGX
Gilles has never mentioned any interest in combining macimorelin with PGX but I was just curious if it was technically desirable what the potential could be. Perplexity Ai: Combining macimorelin
...more
(104)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 30, 2024 5:37am
Macimorelin strategic alliance or licensing deal
CSCI has limited resources but it has now further derisked macimorelin's safety. The pediatric trial has confirmed the "excellent" safety profile of the drug and now with children after
...more
(104)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 30, 2024 4:39am
If we used the gold standard to retest the subjects
I asked Perplexity Ai the following question: If we tracked all of the test subjects down or just the subjects for which there was disagreement between the tests and retested them with the gold
...more
(150)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Comment by
Hopeforthebest
on Aug 29, 2024 10:01pm
RE:RE:RE:RE:RE:Perplexity Ai: The conclusion...
Once again you have reverted back to your usual paid announcement for gagnon. The only thing that gagnon can say to turn this dude which he created through lying to shareholders and never
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec